Payer stocks could rebound after a slow start to 2023

Investors are warming up to payers after Medicare Advantage worries drove a slow start to the year, The Wall Street Journal reported April 11. 

Advertisement

An equal-weighted index of health insurance stocks is on pace for its first annual decline since 2010. 

Despite downturns early in the year, UnitedHealth Group, CVS Health and Humana stocks have been on the rise in the first weeks of April, The Wall Street Journal reported. 

Stock prices rallied after CMS published final Medicare Advantage rates for 2024, which boosted reimbursement rates higher than originally projected and phased in major changes to risk adjustment. 

“All those clouds got lifted within the past few days, but they’ve been pushing the stocks down since late last year,” Emily Evans, health policy analyst at Hedgeye Risk Management, told the Journal. 

Read more here. 

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Advertisement

Next Up in Payer

Advertisement

Comments are closed.